Sectors
MBRX
Moleculin Biotech, Inc.
0.64
2 x 0.45
2 x 0.86
bid
ask
-
0.01
0.80%
2 @ 05:54 PM
0.64 -0.00 (0.71%)
| Ytd | -80.52% | |
| 1y | -93.42% |
0.63
day range
0.67
0.16
52 week range
15.75
| Open | 0.64 | Prev Close | 0.65 | Low | 0.63 | High | 0.67 | Mkt Cap | 12.56M |
| Vol | 290.55K | Avg Vol | 1.24M | EPS | 14.59 | P/E | 0.04 | Forward P/E | -0.29 |
| Beta | 1.83 | Short Ratio | 0.36 | Inst. Own | 15.34% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-08 | 50-d Avg | 1.62 | 200-d Avg | 3.30 | 1yr Est | 18.00 |
| Income Statement | |||
| Operating Expenses | 7.56M | ||
| Research and Development Expense | 5.45M | ||
| Selling, General and Administrative Expense | 2.10M | ||
| Operating Income | -7.56M | ||
| Interest Expense | 78.00K | ||
| Net Income | -7.63M | ||
| Net Income Common Stock | -7.96M | ||
| Net Income Common Stock (USD) | -7.96M | ||
| Consolidated Income | -7.63M | ||
| Earnings per Basic Share | -1.40 | ||
| Earnings per Basic Share (USD) | -1.40 | ||
| Earnings per Diluted Share | -1.40 | ||
| Earning Before Interest & Taxes (EBIT) | -7.56M | ||
| Earning Before Interest & Taxes (USD) | -7.56M | ||
| Preferred Dividends Income Statement Impact | 329.00K | ||
| Weighted Average Shares | 5.68M | ||
| Weighted Average Shares Diluted | 5.68M | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.26M | ||
| Cash and Equivalents (USD) | 7.26M | ||
| Current Assets | 8.72M | ||
| Property, Plant & Equipment Net | 316.00K | ||
| Total Assets | 21.09M | ||
| Total Debt | 147.00K | ||
| Current Liabilities | 9.31M | ||
| Debt Non-Current | 147.00K | ||
| Total Liabilities | 9.50M | ||
| Accumulated Retained Earnings (Deficit) | -226.48M | ||
| Accumulated Other Comprehensive Income | -64.00K | ||
| Shareholders Equity | 11.59M | ||
| Shareholders Equity (USD) | 11.59M | ||
| Assets Non-Current | 12.36M | ||
| Total Debt (USD) | 147.00K | ||
| Goodwill and Intangible Assets | 11.15M | ||
| Liabilities Non-Current | 187.00K | ||
| Trade and Non-Trade Payables | 4.34M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 8.00K | ||
| Net Cash Flow from Financing | 3.61M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.05M | ||
| Issuance (Purchase) of Equity Shares | 3.61M | ||
| Net Cash Flow from Operations | -6.66M | ||
| Effect of Exchange Rate Changes on Cash | -11.00K | ||
| Share Based Compensation | 436.00K | ||